Publications by authors named "Michele Cea"

Claim this Profile
B
Bone marrow immune cell composition reflects multiple myeloma progression and affects treatment response.
Anna Maria Corsale, Mojtaba Shekarkar Azgomi, Emilia Gigliotta, Marta Di Simone, Paola Pacelli, Michele Cea

Blood Neoplasia· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The protective role of HCWs communication for the distress of newly diagnosed people with leukemia and lymphoma.
Fabio Guolo, Francesca Riccardi, Paola Del Sette, Cecilia Perrone, Paola Minetto, Michele Cea

PEC Innov· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow-derived extracellular vesicles from multiple myeloma patients promote adaptive immune dysfunction via HLA-G, PD-1, and PD-L1.
Debora Soncini, Danilo Marimpietri, Francesco Ladisa, Francesco Lai, Irma Airoldi, Michele Cea

Front Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD56 expression modulates NAD+ metabolic landscape and predicts sensitivity to anti-CD38 therapies in multiple myeloma.
Giulia Giorgetti, Elena Maroto-Martin, Debora Soncini, Daniela Fenoglio, Pamela Becherini, Michele Cea

Blood Cancer J· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal gammopathy of renal significance (MGRS): retrospective monocentric analysis of clinical outcomes and treatment strategies.
Pasquale Esposito, Lucia Macciò, Antonia Cagnetta, Francesca Costigliolo, Emilio Venturelli, Michele Cea

Clin Exp Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NAD+ metabolism restriction boosts high-dose melphalan efficacy in patients with multiple myeloma.
Debora Soncini, Pamela Becherini, Francesco Ladisa, Silvia Ravera, Adithya Chedere, Michele Cea

Blood Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Frailty-Based Determinants of Long-Term Mortality in Older Patients with Newly Diagnosed Multiple Myeloma.
Mariya Muzyka, Silvia Ottaviani, Irene Caffa, Tommaso Bonfiglio, Erica Parisi, Michele Cea

Cancers (Basel)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing Outcomes Between CPX-351 and Fludarabine-Based Induction in Secondary Acute Myeloid Leukemia in the Real-World Setting: The Prognostic Role of Measurable Residual Disease.
Carola Riva, Paola Minetto, Maria Chies, Chiara Vernarecci, Nicoletta Colombo, Michele Cea

Hematol Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal hematopoiesis impacts frailty in newly diagnosed multiple myeloma patients: a retrospective multicenter analysis.
Elisa Gelli, Claudia Martinuzzi, Debora Soncini, Concetta Conticello, Francesco Ladisa, Michele Cea

Sci Rep· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real-world retrospective-prospective analysis of efficacy and safety of combined ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma: The northern Italy experience.
Anna Furlan, Michele Cea, Laura Pavan, Monica Galli, Cristina Clissa

Cancer Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Cyclic fasting bolsters cholesterol biosynthesis inhibitors' anticancer activity.
Amr Khalifa, Ana Guijarro, Silvia Ravera, Nadia Bertola, Maria Pia Adorni, Michele Cea

Nat Commun· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclic fasting bolsters cholesterol biosynthesis inhibitors' anticancer activity.
Amr Khalifa, Ana Guijarro, Silvia Ravera, Nadia Bertola, Maria Pia Adorni, Michele Cea

Nat Commun· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab in the treatment of C3 glomerulopathy with monoclonal gammopathy: a case report and literature review.
Pasquale Esposito, Daniela Picciotto, Francesca Costigliolo, Elisa Russo, Lucia Macciò, Michele Cea

Front Med (Lausanne)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing Immune Response in Acute Myeloid Leukemia.
Carola Riva, Chiara Vernarecci, Paola Minetto, Rayan Goda, Marco Greppi, Michele Cea

J Clin Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the deacetylase SIRT6 unveils spliceosome deregulation as exploitable vulnerability for aggressive myeloma.
Elisa Gelli, Debora Soncini, Pamela Becherini, Claudia Martinuzzi, Katia Todoerti, Michele Cea

Blood Adv· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the immune microenvironment in Waldenström macroglobulinemia via halting the CD40/CD40-ligand axis.
Antonio Sacco, Vanessa Desantis, Jon Celay, Viviana Giustini, Fabio Rigali, Michele Cea

Blood· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sirtuin 6 Regulates the Activation of the ATP/Purinergic Axis in Endothelial Cells.
Cecilia Astigiano, Francesco Piacente, Maria Elena Laugieri, Andrea Benzi, Christian A Di Buduo, Michele Cea

Int J Mol Sci· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD-Lowering Agents.
Pamela Becherini, Debora Soncini, Silvia Ravera, Elisa Gelli, Claudia Martinuzzi, Michele Cea

Antioxidants (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticancer Activities of Novel Nicotinamide Phosphoribosyltransferase Inhibitors in Hematological Malignancies.
Paulina Biniecka, Saki Matsumoto, Axel Belotti, Jessie Joussot, Jian Fei Bai, Michele Cea

Molecules· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial.
Roberto Mina, Pellegrino Musto, Delia Rota-Scalabrini, Laura Paris, Barbara Gamberi, Michele Cea

Lancet Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating salivary and serum miRNA-182, 320a, 375 and 503 expression levels in type 2 diabetes.
Yousef Khazaei Monfared, Maryam Honardoost, Michele Cea, Soheyla Gholami, Iraj Mirzaei-Dizgah

J Diabetes Metab Disord· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of new FK866 analogues with potent anticancer activity against pancreatic cancer.
Jian-Fei Bai, Somi Reddy Majjigapu, Bernard Sordat, Sophie Poty, Pierre Vogel, Michele Cea

Eur J Med Chem· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenström Macroglobulinemia.
Eugenio Morelli, Zachary R Hunter, Mariateresa Fulciniti, Annamaria Gullà, Ida Daniela Perrotta, Michele Cea

Exp Hematol Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloma Spine and Bone Damage Score (MSBDS) on Whole-Body Computed Tomography (WBCT): Multiple Reader Agreement in a Multicenter Reliability Study.
Alberto Stefano Tagliafico, Clarissa Valle, Pietro Andrea Bonaffini, Ali Attieh, Matteo Bauckneht, Michele Cea

Diagnostics (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of NAPRT Inhibitors with Anti-Cancer Properties by In Silico Drug Discovery.
Moustafa S Ghanem, Irene Caffa, Alberto Del Rio, Jorge Franco, Marco Daniele Parenti, Michele Cea

Pharmaceuticals (Basel)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis